accountassistance of Rs 100 million from the Department of Biotechnology, Government of India, for the development of the swine flu vaccine. The grant has been given as a long-term loan on a concessional interest rate of 2 per cent per annum and the firm has...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Panacea gets Rs 100 mn grant for swine flu vaccine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account